-

Velum Prime and Movento Manage Nematodes for Better Yields and Improved Plant Health in Pacific Northwest

V+M Solution provides nematode suppression and boosts yield potential

ST. LOUIS--(BUSINESS WIRE)--With the potential to cause up to 90 percent annual yield loss, nematodes can be a key threat to a potato crop. Nematodes affect potatoes directly by feeding on roots and tubers and indirectly through transmission of diseases. To protect yields and plant health, growers should take action either at planting or in-season to mitigate damage.

Velum® Prime nematicide and Movento® insecticide can help growers prevent damage from nematodes and provide a yield boost in potato fields. In fact, in trials held in Connell, Washington, this combination of Velum Prime nematicide and Movento insecticide increased marketable yield by 82 cwt/A, as compared to Vydate® insecticide/nematicide, under heavy nematode pressure (Figure 1).

Velum Prime plus Movento from Bayer provide a systemic solution designed to protect root health and maximize potato yield potential. Called the V+M Solution, the combination of these tools can boost plant health by not only preventing below-ground plant parasitic nematodes but other above-ground damaging pests such as mites and insects, including psyllids and aphids.

“The V+M program for nematode management is effective because you put the Velum Prime in-furrow at planting to affect the nematodes in the soil,” said Dr. Saad Hafez, nematology professor and Extension specialist at the University of Idaho. “And then you come back before closing and put the Velum and Movento applications and that will stop whatever nematodes get in the root system.”

Velum Prime nematicide is an innovative, non-fumigant nematicide with disease-management benefits. It can be applied in-furrow during planting or early in the potato-growing season via overhead chemigation. Due to its nematode suppression, Velum Prime protects root health to help establish the crop, leading to improved yield potential. In addition, Velum Prime has systemic movement that effectively suppresses key soil and foliar diseases, including early blight and white mold.

Movento insecticide offers two-way movement both upward and downward within plant tissue to protect against pests, including nematodes. Specifically, Movento manages adult female pests, reducing fecundity and limiting the survival of their offspring, therefore providing more effective reduction of overall pest pressure. With its allover plant protection, Movento also protects against the diseases associated with key pests such as potato leaf roll virus, potato virus Y, zebra chip disease, and Verticillium wilt. With long-lasting protection and a high level of residual efficacy, Movento also protects new foliage, root and tuber growth.

“Movento fits in really nicely because it has minimal impact on all the beneficials, the ladybugs and other things that feed on aphids and thrips,” said Kamren Koompin, an Idaho potato grower. “Having that added nematode benefit, along with Velum Prime on those fields, I think really helps with late season plant health.”

“The V+M Solution is attractive to growers because you can get both nematode and disease suppression,” said Hafez. “And really, once you get a healthy vine, you get a really good yield response.”

To learn more about Velum Prime and Movento, please contact your Bayer representative or visit https://www.cropscience.bayer.us/products/insecticides/movento/velum-prime-and-movento.

Bayer is committed to bringing new technology and solutions for agriculture and non-agricultural uses. For questions concerning the availability and use of products, contact a local Bayer representative, or visit Crop Science, a division of Bayer, online at www.cropscience.bayer.us.

Visit the Bayer Connect - Social Hub for social media, recent news, blog posts, videos and more from Crop Science, a division of Bayer.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.us.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

ALWAYS READ AND FOLLOW PESTICIDE LABEL DIRECTIONS. Not all products are registered in all states and may be subject to use restrictions. The distribution, sale, or use of an unregistered pesticide is a violation of federal and/or state law and is strictly prohibited. Check with your local dealer or representative for the product registration status in your state. Bayer, Bayer Cross, Movento® and Velum® are registered trademarks of Bayer Group. All other trademarks are the property of their respective owners. For additional product information call toll-free 1-866-99-BAYER (1-866-992-2937) or visit our website at www.BayerCropScience.us. Bayer CropScience LP, 800 North Lindbergh Boulevard, St. Louis, MO 63167. ©2020 Bayer Group. All rights reserved.

Find more information at www.cropscience.bayer.us.

Contacts

Bayer Media Hotline, 1-862-404-5118

or
Tyler Schwertner
Bayer
Tel: (325) 812-3676
Email: tyler.schwertner@bayer.com

Elizabeth Smith
Rhea + Kaiser
Tel: (630) 955-2601
Email: esmith@rkconnect.com

Bayer


Release Versions

Contacts

Bayer Media Hotline, 1-862-404-5118

or
Tyler Schwertner
Bayer
Tel: (325) 812-3676
Email: tyler.schwertner@bayer.com

Elizabeth Smith
Rhea + Kaiser
Tel: (630) 955-2601
Email: esmith@rkconnect.com

More News From Bayer

One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin

WHIPPANY, N.J.--(BUSINESS WIRE)--One A Day®, the multivitamin and supplement brand from Bayer, today announced a new formula for One A Day® Women's Multi Gummy, which now delivers 1,000 mcg of Biotin per serving (serving size is two gummies). The new formulation contains more biotin† with 2833% Daily Value (DV) than other leading multivitamin gummies including Olly Women’s Multi, Nature Made Women's Advanced Multivitamin Gummies, and Vitafusion Women's Multi (1000 mcg vs 150 mcg), while continu...

New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters

LEVERKUSEN, Germany--(BUSINESS WIRE)--Self-care, when effectively integrated into health systems, can improve health outcomes, expand access to healthcare services and reduce pressure on overstretched health systems, according to new research by Economist Enterprise. The research, supported by Bayer and published in a report titled “Making self-care work: integrating self-care into health systems”, cites existing evidence estimating that self-care practices can deliver approximately US$ 179 bil...

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

DETROIT--(BUSINESS WIRE)--Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scie...
Back to Newsroom